GEN PROBE INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2014-01: Study NCT02026752; Company role Lead sponsor; Phase Observational; Status Completed.
- 2013-01: Study NCT01728103; Company role Lead sponsor; Phase Observational; Status Terminated.
- 2013-01: Study NCT01702272; Company role Lead sponsor; Phase Observational; Status Completed.
- 2012-10: Study NCT01694875; Company role Lead sponsor; Phase Observational; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2014-01 | NCT02026752 Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay | Lead sponsor | Observational | Completed | HIV-1 Infection | 468 | 2017-01 |
| 2013-01 | NCT01728103 Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays | Lead sponsor | Observational | Terminated | Chlamydia Infections; Gonorrhea; Trichomonas Infections | 1,336 | |
| 2013-01 | NCT01702272 Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS | Lead sponsor | Observational | Completed | Dengue | 150,000 | 2014-01 |
| 2012-10 | NCT01694875 Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System | Lead sponsor | Observational | Completed | Human Papillomavirus Infection | 2,200 | 2012-11 |
| 2012-08 | NCT01656174 Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross | Lead sponsor | Observational | Completed | Dengue | 35,035 | 2015-01 |
| 2012-08 | NCT01427023 Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing | Lead sponsor | Observational | Completed | Trichomonas Vaginalis | 532 | 2013-12 |
| 2012-03 | NCT01446198 Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System | Lead sponsor | Observational | Completed | Human Papilloma Virus Infection | 11,816 | 2012-05 |
| 2012-02 | NCT01638637 Prospective Collection of Female and Male Specimens for PANTHER® System Testing | Lead sponsor | Observational | Completed | Chlamydia Infections; Gonorrhea | 1,492 | 2013-07 |
| 2011-06 | NCT01384370 APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results | Lead sponsor | Observational | Completed | Human Papillomavirus Infection | 1,260 | 2011-08 |
| 2010-11 | NCT01733069 Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System | Lead sponsor | Observational | Completed Results posted | Chlamydia Trachomatis; Neisseria Gonorrhoeae Infection | 1,912 | 2012-02 |
| 2010-11 | NCT01358799 Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System | Lead sponsor | Observational | Withdrawn | Chlamydia Trachomatis | 0 | 2012-01 |
| 2009-11 | NCT00978848 Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing | Collaborator Lead: University of Pittsburgh | Observational | Completed | Trichomonas Vaginitis; Chlamydia Trachomatis; Neisseria Gonorrhoeae Infection | 305 | 2010-04 |
| 2009-08 | NCT01024959 Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result | Lead sponsor | Not applicable | Completed Results posted | Prostatic Neoplasms | 507 | 2010-04 |
| 2009-04-06 | NCT00877682 Prostate Conformal Cryotherapy | Collaborator Lead: M.D. Anderson Cancer Center | Not applicable | Completed | Prostate Cancer | 48 | 2018-01-14 |
| 2008-03 | NCT00973362 Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System | Lead sponsor | Phase 3 | Completed Results posted | Human Papillomavirus Infection | 12,896 | 2014-04 |
| 1990-04 | NCT00578240 Molecular Studies and Clinical Correlations in Human Prostatic Disease | Collaborator Lead: Memorial Sloan Kettering Cancer Center | Observational | Active not recruiting | Prostate Cancer | 5,290 | 2026-12 |